Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-25 4:23 pm Purchase | 2026-08-19 | 13D | MOLECULIN BIOTECH INC PAR MBRX | Foster Jonathan P. | 64,410 6.300% | 64,410![]() (New Position) | Filing History |
| 2026-08-25 4:22 pm Purchase | 2026-08-19 | 13D | MOLECULIN BIOTECH INC PAR MBRX | KLEMP WALTER V | 103,538 9.900% | 103,538![]() (New Position) | Filing History |
| 2026-08-10 6:37 pm Purchase | 2026-07-31 | 13G | MOLECULIN BIOTECH INC PAR MBRX | CVI Investments, Inc. | 93,169 9.900% | 93,129![]() (+232822.50%) | Filing History |
| 2026-08-06 5:26 pm Purchase | 2026-07-31 | 13G | MOLECULIN BIOTECH INC PAR MBRX | Mitchell P. Kopin | 48,696 4.990% | 48,679![]() (+286347.06%) | Filing History |
| 2025-08-14 9:13 pm Purchase | 2025-06-30 | 13G | MOLECULIN BIOTECH INC PAR MBRX | Armistice Capital, LLC | 3,173 4.990% | 673![]() (+26.92%) | Filing History |
| 2025-05-15 3:30 pm Purchase | 2025-03-31 | 13G | MOLECULIN BIOTECH INC PAR MBRX | Armistice Capital, LLC | 2,500 8.930% | 1,820![]() (+267.65%) | Filing History |
| 2025-02-14 5:51 pm Purchase | 2024-12-31 | 13G | MOLECULIN BIOTECH INC PAR MBRX | Armistice Capital, LLC | 680 9.990% | 78![]() (+12.96%) | Filing History |
| 2024-11-14 5:12 pm Purchase | 2024-09-30 | 13G | MOLECULIN BIOTECH INC PAR MBRX | Armistice Capital, LLC | 602 9.990% | 160![]() (+36.20%) | Filing History |
| 2024-02-14 3:43 pm Purchase | 2023-12-31 | 13G | MOLECULIN BIOTECH INC MBRX | Armistice Capital, LLC | 442 9.990% | 420![]() (+1909.09%) | Filing History |
